JPMorgan Chase & Co’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.23M Buy
443,375
+4,069
+0.9% +$20.5K ﹤0.01% 3263
2025
Q1
$2.85M Sell
439,306
-1,367,711
-76% -$8.86M ﹤0.01% 3035
2024
Q4
$13.3M Buy
1,807,017
+720,690
+66% +$5.29M ﹤0.01% 2034
2024
Q3
$8.14M Sell
1,086,327
-168,971
-13% -$1.27M ﹤0.01% 2292
2024
Q2
$11.2M Buy
1,255,298
+792,051
+171% +$7.05M ﹤0.01% 2039
2024
Q1
$4.69M Buy
463,247
+236,700
+104% +$2.4M ﹤0.01% 2616
2023
Q4
$2.28M Buy
226,547
+71,557
+46% +$720K ﹤0.01% 3065
2023
Q3
$1.45M Sell
154,990
-78,529
-34% -$736K ﹤0.01% 3200
2023
Q2
$5.73M Buy
233,519
+107,164
+85% +$2.63M ﹤0.01% 2405
2023
Q1
$2.94M Sell
126,355
-23,264
-16% -$541K ﹤0.01% 2805
2022
Q4
$3.79M Buy
149,619
+65,984
+79% +$1.67M ﹤0.01% 2565
2022
Q3
$1.61M Buy
83,635
+679
+0.8% +$13.1K ﹤0.01% 3058
2022
Q2
$2.11M Buy
82,956
+2,983
+4% +$75.9K ﹤0.01% 2967
2022
Q1
$2.06M Sell
79,973
-101,849
-56% -$2.62M ﹤0.01% 3149
2021
Q4
$7.61M Sell
181,822
-754
-0.4% -$31.6K ﹤0.01% 2287
2021
Q3
$7.95M Sell
182,576
-27,652
-13% -$1.2M ﹤0.01% 2240
2021
Q2
$9.94M Buy
210,228
+89
+0% +$4.21K ﹤0.01% 2150
2021
Q1
$10.8M Buy
210,139
+64,841
+45% +$3.32M ﹤0.01% 2074
2020
Q4
$3.89M Buy
145,298
+27,775
+24% +$744K ﹤0.01% 2580
2020
Q3
$4.43M Sell
117,523
-4,008
-3% -$151K ﹤0.01% 2300
2020
Q2
$4.98M Sell
121,531
-124
-0.1% -$5.08K ﹤0.01% 2156
2020
Q1
$4.17M Buy
121,655
+21,914
+22% +$751K ﹤0.01% 2128
2019
Q4
$1.26M Buy
+99,741
New +$1.26M ﹤0.01% 2936